Veteran subjects willingness to participate in schizophrenia clinical trials.

about

Progress in compliance research and intervention: a commentary.

P2860

Q37236153-7FB1898F-107C-4CB0-946E-1E69AA8E7D51

P2860

Veteran subjects willingness to participate in schizophrenia clinical trials.

Item

http://www.wikidata.org/entity/Q45329830

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Veteran subjects willingness to participate in schizophrenia clinical trials.

@en

Veteran subjects willingness to participate in schizophrenia clinical trials.

@nl

type

Item

label

Veteran subjects willingness to participate in schizophrenia clinical trials.

@en

Veteran subjects willingness to participate in schizophrenia clinical trials.

@nl

prefLabel

Veteran subjects willingness to participate in schizophrenia clinical trials.

@en

Veteran subjects willingness to participate in schizophrenia clinical trials.

@nl

P1476

Veteran subjects willingness to participate in schizophrenia clinical trials.

@en

P2093

CSP 555 Investigator Group

http://www.w3.org/2001/XMLSchema#string

J C Hoblyn

http://www.w3.org/2001/XMLSchema#string

L Weil

http://www.w3.org/2001/XMLSchema#string

R A Rosenheck

http://www.w3.org/2001/XMLSchema#string

Robert Lew

http://www.w3.org/2001/XMLSchema#string

S Leatherman

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients

From clinical trials to real-world practice: use of atypical antipsychotic medication nationally in the Department of Veterans Affairs.

Effect of study criteria on recruitment and generalizability of the results.

Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.

Sex selection bias in schizophrenia antipsychotic trials.

Subject selection biases in clinical trials: data from a multicenter schizophrenia treatment study.

First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies.

Informed consent as a form of volunteer bias.

What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?

The personal impact of schizophrenia in Europe.

P2888

s11126-012-9240-4

P304

209-218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11126-012-9240-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1018133847

http://www.w3.org/2001/XMLSchema#string

P698

23143523

http://www.w3.org/2001/XMLSchema#string

P921

veteran

schizophrenia

Veteran subjects willingness to participate in schizophrenia clinical trials.

about

P2860

P2860

Veteran subjects willingness to participate in schizophrenia clinical trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921